chr16-5071864-C-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000262374.10(ALG1):c.15C>A(p.Cys5Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,452,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C5C) has been classified as Likely benign.
Frequency
Consequence
ENST00000262374.10 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG1 | NM_019109.5 | c.15C>A | p.Cys5Ter | stop_gained | 1/13 | ENST00000262374.10 | NP_061982.3 | |
ALG1 | XM_017023457.3 | c.15C>A | p.Cys5Ter | stop_gained | 1/12 | XP_016878946.1 | ||
ALG1 | XR_007064892.1 | n.22C>A | non_coding_transcript_exon_variant | 1/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG1 | ENST00000262374.10 | c.15C>A | p.Cys5Ter | stop_gained | 1/13 | 1 | NM_019109.5 | ENSP00000262374 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000863 AC: 2AN: 231758Hom.: 0 AF XY: 0.00000786 AC XY: 1AN XY: 127152
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1452444Hom.: 0 Cov.: 31 AF XY: 0.00000277 AC XY: 2AN XY: 722642
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Congenital disorder of glycosylation Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | University of Washington Center for Mendelian Genomics, University of Washington | May 25, 2017 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 27, 2015 | - - |
ALG1-congenital disorder of glycosylation Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 18, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at